Views: 92 Author: Site Editor Publish Time: 2025-02-10 Origin: Site
Dubai, UAE, February 2025 – Medlere, a global provider of in vitro diagnostic (IVD) solutions, participated in Medlab Middle East 2025, held at the Dubai World Trade Centre. The exhibition brought together laboratory professionals, distributors, and healthcare providers from across the region and beyond.
During the four-day event, the Medlere booth attracted strong interest from visitors seeking reliable, cost-effective diagnostic solutions adaptable to both centralized laboratories and decentralized healthcare settings. Discussions focused not only on product capabilities, but also on long-term collaboration, local market needs, and regulatory pathways.
Medlere presented a range of diagnostic solutions designed to support laboratories of different sizes:
FiCA Immunofluorescence Analyzer: A multi-parameter platform supporting routine and specialty testing in decentralized and clinical laboratory environments.
UClia Chemiluminescence Analyzer: A compact system combining chemiluminescence sensitivity with point-of-care flexibility for rapid testing scenarios.
i-Hema Hematology Analyzer: A hematology solution designed for reliable and efficient blood analysis in routine laboratory workflows.
M3 HPLC HbA1c Analyzer: An ion-exchange HPLC system supporting standardized HbA1c testing for diabetes management.
Live demonstrations at the booth provided hands-on experience with Medlere’s diagnostic systems, highlighting their ease of use and adaptability across different clinical settings.
Beyond product demonstrations, Medlab Middle East 2025 served as a platform for meaningful business engagement. The Medlere team conducted in-depth discussions with potential partners, many of whom expressed strong interest in distribution opportunities and localized cooperation models.
The company noted a clear trend: healthcare providers in emerging markets are increasingly prioritizing solutions that balance accuracy, operational efficiency, and affordability—a space where Medlere continues to expand its value proposition.
Medlere’s participation in Medlab Middle East 2025 reflects its broader strategy to build a more connected global network and to deliver diagnostic solutions that are not only technologically advanced, but also practically accessible across diverse healthcare systems.
About Medlere Limited:
Medlere Limited is a medical diagnostics company focused on developing innovative in vitro diagnostic (IVD) solutions. The company aims to improve healthcare accessibility and laboratory efficiency through reliable, user-oriented technologies and continuous innovation. For more information, please visit www.medlere.com or contact: info@medlere.com
